
The Analyst
Following Cresco Labs’ (OTC:CRLBF) (CSE:CL) conference call, Pablo Zuanic, from Cantor Fitzgerald kept an "Overweight" rating and maintained a 12-month price target of $19.

Following Cresco Labs’ (OTC:CRLBF) (CSE:CL) conference call, Pablo Zuanic, from Cantor Fitzgerald kept an "Overweight" rating and maintained a 12-month price target of $19.